Ability Biologics Unveils Discovery Platform that Generates Antibodies with Unparalleled Specificity and Selectivity
Company emerges from stealth with the closing of $12 million seed funding December 06, 2023 07:00 AM Eastern Standard Time MONTREAL–(BUSINESS WIRE)–Ability Biologics (“Ability” or “the company”) announced the closing of its $12 million (US)…